Chronic neuropathic pain following oxaliplatin and docetaxel: A 5-year follow-up questionnaire study

Chronic neuropathic pain following oxaliplatin and docetaxel: A 5-year follow-up questionnaire study 166Scientific presentations at the 2017 Annual Meeting / Scandinavian Journal of Pain 16 (2017) 165–188muscle, C5/C6 joint, second metacarpal and tibialis anterior toassess widespread pressure hyperalgesia.Results: Side-to-side consistency between DPT (r = 0.769,P < 0.001) was found. DPT was moderately associated withwidespread PPTs (0.364 > r > 0.769, all P < 0.001). No significantassociation with migraine pain features (frequency, intensity orduration of migraine attack) were observed (all, P > 0.129). Associations were similar in women with episodic or chronic migraine.Conclusions: Dynamic pressure algometry was valid forassessing dynamic mechanical muscle allodynia in migraine. DPTwas associated with widespread static muscle hyperalgesia independently of migraine frequency supporting that dynamic muscleallodynia in the trigeminal area is consistent with generalized pressure pain hyperalgesia. Assessing dynamic deep somatic tissuesensitivity may provide a new tool for assessing treatment effects.http://dx.doi.org/10.1016/j.sjpain.2017.04.007The number of active trigger points isassociated with sensory and emotional aspectsof health-related quality of life in tension typeheadache˜ a,b , K. Wang a , M. Castaldo a , S.M. Palacios-CenaFuensalida-Novo b , C. Ordás-Bandera c , A.Guillem-Mesado d , L. Arendt-Nielsen a,∗ , C.˜ a,bFernández-de-las-PenasaDepartment of Health Science and Technology,Aalborg University, Aalborg, Denmarkb Departamento de Fisioterapia, TerapiaOcupacional, Rehabilitación y Medicina Física,Universidad Rey Juan Carlos, Alcorcón, Madrid, Spainc Neurology Department. Hospital Rey Juan Carlos,Madrid, Spaind Neurology Department, Hospital GregorioMara˜nón, Madrid, SpainE-mail address: cesar.fernandez@urjc.es (C. Fernández-de-las˜Penas).Aims: Some evidence supports that referred pain elicited byactive trigger points (TrPs) reproduces some features of tensiontype headache (TTH). Our aim was to investigate the associationbetween the number of active TrPs and health-related quality oflife TTH.Methods: Patients with TTH diagnosed by experienced neurologists according to the last International Headache Classification(ICHD-III) were included. Exclusion criteria included other primary headaches, medication overuse headache, whiplash injuryor fibromyalgia. TrPs were bilaterally explored within the masseter, temporalis, trapezius, sternocleidomastoid, splenius capitis,and suboccipital. Health-related quality of life was assessed withthe SF-36 questionnaire including 8 domains: physical functioning,physical role, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. Higher scores representbetter quality of life. Spearman correlation coefficients were usedto determine correlations between the active TrPs and SF-36.Results: Two hundred and two patients (mean age: 45 ± 12years) with a headache frequency of 17 ± 7 days/month participated. Each patient with TTH exhibited 4.7 ± 2.9 active TrPs. Thenumber of active TrPs showed moderate weak negative associations with bodily pain (rs : −0.216; P = 0.002), emotional role (rs :−0.185; P = 0.008) and vitality (rs : −0.161; P = 0.02), but not with theremaining domains: the higher the number of active TrPs, the worsethe emotional role and vitality and the higher the pain interferencewith daily life. These results were similar in both frequent episodicand chronic TTH.Conclusions: The number of active TrPs was associated withsensory and emotional aspects of quality of life in a cohort of subjects with TTH.http://dx.doi.org/10.1016/j.sjpain.2017.04.008Chronic neuropathic pain following oxaliplatinand docetaxel: A 5-year follow-upquestionnaire studyK.J. Bennedsgaard a,∗ , L. Ventzel b , A.B. Jensen b ,A.R. Jensen b , H. Tankisi c , N.B. Finnerup aaDanish Pain Research Center, Department ofClinical Medicine, Aarhus University, Aarhus,Denmarkb Department of Oncology, Aarhus UniversityHospital, Aarhus, Denmarkc Department of Clinical Neurophysiology, AarhusUniversity Hospital, Aarhus, DenmarkE-mail address: krbenn@clin.au.dk (K.J. Bennedsgaard).Background: Adjuvant chemotherapy with docetaxel andoxaliplatin increases survival in patients with high-risk breastand colorectal cancer, respectively, but may induce acute andchronic neurotoxicity. This study is a 5-year follow-up of chronicchemotherapy-induced peripheral neuropathy (CIPN).Methods: In 2011–2012, 74 patients with high-risk colorectalcancer and 100 patients with high-risk breast cancer answereda questionnaire before, during and one year after receiving adjuvant chemotherapy with oxaliplatin and docetaxel, respectively.In 2016, a 5-year follow-up with the same questionnaire was performed in survivors.Results: Fifty-two (36.5% women) of 74 patients (91%) treatedwith oxaliplatin and 80 (100% women) of 100 patients (85%) treatedwith docetaxel answered the questionnaire. The most commonsymptoms of CIPN were tingling in the hands (44.2% in the oxaliplatin (CI 95% 30.5; 58.7) and 36.3% in the docetaxel group (CI 95%25.8; 47.8)) and feet (52.0% in the oxaliplatin (CI 95% 37.6; 66.0)and 37.5% (CI 95% 29.9; 49.0) in the docetaxel group) and numbness in the feet (34.6% in the oxaliplatin (CI 95% 22.0; 49.1) and17.5% (CI 95% 9.9; 27.6) in the docetaxel group). Pain was presentin the hands or feet in 28.9% of patients treated with oxaliplatin (CI95% 17.12; 43.0) and 31.3% of patients treated with docetaxel (CI95% 21.3; 42.6).Conclusions: The results showed no major change in symptomsof neuropathy or pain from 1 to 5 years after chemotherapy. Symptoms of neuropathy were more common in patients treated withoxaliplatin.http://dx.doi.org/10.1016/j.sjpain.2017.04.009 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Pain de Gruyter

Chronic neuropathic pain following oxaliplatin and docetaxel: A 5-year follow-up questionnaire study

Free
1 page

Loading next page...
1 Page
 
/lp/degruyter/chronic-neuropathic-pain-following-oxaliplatin-and-docetaxel-a-5-year-Gm8a9EHLQY
Publisher
De Gruyter
Copyright
© 2017 Scandinavian Association for the Study of Pain
ISSN
1877-8860
eISSN
1877-8879
D.O.I.
10.1016/j.sjpain.2017.04.009
Publisher site
See Article on Publisher Site

Abstract

166Scientific presentations at the 2017 Annual Meeting / Scandinavian Journal of Pain 16 (2017) 165–188muscle, C5/C6 joint, second metacarpal and tibialis anterior toassess widespread pressure hyperalgesia.Results: Side-to-side consistency between DPT (r = 0.769,P < 0.001) was found. DPT was moderately associated withwidespread PPTs (0.364 > r > 0.769, all P < 0.001). No significantassociation with migraine pain features (frequency, intensity orduration of migraine attack) were observed (all, P > 0.129). Associations were similar in women with episodic or chronic migraine.Conclusions: Dynamic pressure algometry was valid forassessing dynamic mechanical muscle allodynia in migraine. DPTwas associated with widespread static muscle hyperalgesia independently of migraine frequency supporting that dynamic muscleallodynia in the trigeminal area is consistent with generalized pressure pain hyperalgesia. Assessing dynamic deep somatic tissuesensitivity may provide a new tool for assessing treatment effects.http://dx.doi.org/10.1016/j.sjpain.2017.04.007The number of active trigger points isassociated with sensory and emotional aspectsof health-related quality of life in tension typeheadache˜ a,b , K. Wang a , M. Castaldo a , S.M. Palacios-CenaFuensalida-Novo b , C. Ordás-Bandera c , A.Guillem-Mesado d , L. Arendt-Nielsen a,∗ , C.˜ a,bFernández-de-las-PenasaDepartment of Health Science and Technology,Aalborg University, Aalborg, Denmarkb Departamento de Fisioterapia, TerapiaOcupacional, Rehabilitación y Medicina Física,Universidad Rey Juan Carlos, Alcorcón, Madrid, Spainc Neurology Department. Hospital Rey Juan Carlos,Madrid, Spaind Neurology Department, Hospital GregorioMara˜nón, Madrid, SpainE-mail address: cesar.fernandez@urjc.es (C. Fernández-de-las˜Penas).Aims: Some evidence supports that referred pain elicited byactive trigger points (TrPs) reproduces some features of tensiontype headache (TTH). Our aim was to investigate the associationbetween the number of active TrPs and health-related quality oflife TTH.Methods: Patients with TTH diagnosed by experienced neurologists according to the last International Headache Classification(ICHD-III) were included. Exclusion criteria included other primary headaches, medication overuse headache, whiplash injuryor fibromyalgia. TrPs were bilaterally explored within the masseter, temporalis, trapezius, sternocleidomastoid, splenius capitis,and suboccipital. Health-related quality of life was assessed withthe SF-36 questionnaire including 8 domains: physical functioning,physical role, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. Higher scores representbetter quality of life. Spearman correlation coefficients were usedto determine correlations between the active TrPs and SF-36.Results: Two hundred and two patients (mean age: 45 ± 12years) with a headache frequency of 17 ± 7 days/month participated. Each patient with TTH exhibited 4.7 ± 2.9 active TrPs. Thenumber of active TrPs showed moderate weak negative associations with bodily pain (rs : −0.216; P = 0.002), emotional role (rs :−0.185; P = 0.008) and vitality (rs : −0.161; P = 0.02), but not with theremaining domains: the higher the number of active TrPs, the worsethe emotional role and vitality and the higher the pain interferencewith daily life. These results were similar in both frequent episodicand chronic TTH.Conclusions: The number of active TrPs was associated withsensory and emotional aspects of quality of life in a cohort of subjects with TTH.http://dx.doi.org/10.1016/j.sjpain.2017.04.008Chronic neuropathic pain following oxaliplatinand docetaxel: A 5-year follow-upquestionnaire studyK.J. Bennedsgaard a,∗ , L. Ventzel b , A.B. Jensen b ,A.R. Jensen b , H. Tankisi c , N.B. Finnerup aaDanish Pain Research Center, Department ofClinical Medicine, Aarhus University, Aarhus,Denmarkb Department of Oncology, Aarhus UniversityHospital, Aarhus, Denmarkc Department of Clinical Neurophysiology, AarhusUniversity Hospital, Aarhus, DenmarkE-mail address: krbenn@clin.au.dk (K.J. Bennedsgaard).Background: Adjuvant chemotherapy with docetaxel andoxaliplatin increases survival in patients with high-risk breastand colorectal cancer, respectively, but may induce acute andchronic neurotoxicity. This study is a 5-year follow-up of chronicchemotherapy-induced peripheral neuropathy (CIPN).Methods: In 2011–2012, 74 patients with high-risk colorectalcancer and 100 patients with high-risk breast cancer answereda questionnaire before, during and one year after receiving adjuvant chemotherapy with oxaliplatin and docetaxel, respectively.In 2016, a 5-year follow-up with the same questionnaire was performed in survivors.Results: Fifty-two (36.5% women) of 74 patients (91%) treatedwith oxaliplatin and 80 (100% women) of 100 patients (85%) treatedwith docetaxel answered the questionnaire. The most commonsymptoms of CIPN were tingling in the hands (44.2% in the oxaliplatin (CI 95% 30.5; 58.7) and 36.3% in the docetaxel group (CI 95%25.8; 47.8)) and feet (52.0% in the oxaliplatin (CI 95% 37.6; 66.0)and 37.5% (CI 95% 29.9; 49.0) in the docetaxel group) and numbness in the feet (34.6% in the oxaliplatin (CI 95% 22.0; 49.1) and17.5% (CI 95% 9.9; 27.6) in the docetaxel group). Pain was presentin the hands or feet in 28.9% of patients treated with oxaliplatin (CI95% 17.12; 43.0) and 31.3% of patients treated with docetaxel (CI95% 21.3; 42.6).Conclusions: The results showed no major change in symptomsof neuropathy or pain from 1 to 5 years after chemotherapy. Symptoms of neuropathy were more common in patients treated withoxaliplatin.http://dx.doi.org/10.1016/j.sjpain.2017.04.009

Journal

Scandinavian Journal of Painde Gruyter

Published: Dec 29, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial